Clinical Trials Logo

Panic clinical trials

View clinical trials related to Panic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05292807 Recruiting - Social Anxiety Clinical Trials

Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms

Start date: April 14, 2022
Phase: N/A
Study type: Interventional

This study will recruit 460 participants who self-report high symptoms of anxiety. Participants will be randomly assigned to one of 4 groups: one analog intervention of Imagery Rescripting (IR) for memories, an analog intervention of IR for future events, and analog intervention of Imaginal Exposure (IE) for memories and an analog intervention of IE for future events. We will examine the efficacy and mechanisms behind each intervention.

NCT ID: NCT04811521 Enrolling by invitation - Clinical trials for Generalized Anxiety Disorder

Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room

PACER
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The goal of this research is to compare the benefits and risks of three anxiety treatments that are pragmatic, graduated in the level of resource intensity, and have demonstrated efficacy and feasibility for real world adoption.

NCT ID: NCT04634461 Enrolling by invitation - Panic Disorder Clinical Trials

The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.

Start date: March 15, 2021
Phase:
Study type: Observational

To characterize the relationship between panic attack symptoms and atrial fibrillation episodes using a real-time assessment data capturing system that reduces recall biases of previous research.

NCT ID: NCT04577612 Completed - Anxiety Clinical Trials

A Randomized Controlled Test of the Effects of CHI-554 on Fear.

Start date: September 1, 2020
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled phase 2b clinical trial examining the effects of CHI-554 (CBD) on Fear (F-01)